Guthrie Medical Group
Sayre, Pennsylvania, 18840, United States
NCT Number: NCT03615573
A survey study to evaluate the financial impact of breast cancer as self-reported by breast cancer patients over a period of 1 year. The study will also look at the health insurance literacy and patient's utilization of support services.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Sayre, Pennsylvania, 18840, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with breast cancer diagnosis complete questionnaires over 20-30 minutes at baseline and at 3, 6, and 12 months after enrollment.
Time frame: Baseline through 1 year
Will evaluate the change in Comprehensive Score for Financial Toxicity (COST-FACIT) measurements from baseline to 1 year follow up. This survey consists of 14 questions related to finances.Responses include 5 options with lower scores representing worse outcomes. Scores at 1 year will be compared to baseline scores.
Time frame: Baseline through 1 year
Will evaluate the change in Health Insurance Literacy Measurements (HILM) from baseline to 1 year follow up
Time frame: Baseline through 1 year
Will evaluate reported access and utilization of institutional support services and its association to financial burden in the first 12 months after enrollment.
The Guthrie Clinic
Other
Determining the Financial Impact of Breast Cancer Treatment Over a One Year Period for Patients at a Rural Cancer Center
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details